143 related articles for article (PubMed ID: 28761279)
1. Role of sclerotherapy in management of vascular malformation in the maxillofacial region: Our experience.
Mishra M; Singh G; Gaur A; Tandon S; Singh A
Natl J Maxillofac Surg; 2017; 8(1):64-69. PubMed ID: 28761279
[TBL] [Abstract][Full Text] [Related]
2. Management of mandibular vascular malformation with sclerotherapy. Report of two cases.
Hassani A; Khojasteh A; Vahid R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul; 102(1):99-103. PubMed ID: 16831680
[TBL] [Abstract][Full Text] [Related]
3. A new venture with sclerotherapy in an oral vascular lesion.
Sitra G; Kayalvizhi EB; Sivasankari T; Vishwanath R
J Basic Clin Pharm; 2014 Dec; 6(1):40-3. PubMed ID: 25538471
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of a Low-Dose Sclerosing Agent for the Treatment of Vascular Lesions in the Tongue.
Lim T; Kim D; Lee HW; Ohe JY; Jung J
Cureus; 2023 Sep; 15(9):e45323. PubMed ID: 37849611
[TBL] [Abstract][Full Text] [Related]
5. Utility of intralesional sclerotherapy with 3% sodium tetradecyl sulphate in cutaneous vascular malformations.
Khandpur S; Sharma VK
Dermatol Surg; 2010 Mar; 36(3):340-6. PubMed ID: 20100267
[TBL] [Abstract][Full Text] [Related]
6. Sodium tetradecyl sulphate sclerotherapy for treating venous malformations of the oral and pharyngeal regions in children.
Stimpson P; Hewitt R; Barnacle A; Roebuck DJ; Hartley B
Int J Pediatr Otorhinolaryngol; 2012 Apr; 76(4):569-73. PubMed ID: 22341629
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Head and Neck Venous Malformations with Sodium Tetradecyl Sulfate.
Karimi E; Jafari M; Aghazadeh K; Sohrabpour S; Tavakolnejad F
OTO Open; 2018; 2(3):2473974X18797067. PubMed ID: 31535070
[TBL] [Abstract][Full Text] [Related]
8. Sodium tetradecyl sulphate direct intralesional sclerotherapy of venous malformations of the vulva and vagina: report of five cases.
Krokidis M; Venetucci P; Hatzidakis A; Iaccarino V
Cardiovasc Intervent Radiol; 2011 Feb; 34 Suppl 2():S228-31. PubMed ID: 20559638
[TBL] [Abstract][Full Text] [Related]
9. Utility of sodium tetradecyl sulfate sclerotherapy from benign oral vascular lesion.
Choi BE; Kim Y; Leem DH; Baek JA; Ko SO
Maxillofac Plast Reconstr Surg; 2016 Dec; 38(1):44. PubMed ID: 27995117
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of intralesional sclerotherapy with sodium tetradecyl sulfate versus bleomycin in the management of low flow craniofacial soft tissue vascular lesions.
Bajpai H; Bajpai S
J Maxillofac Oral Surg; 2012 Mar; 11(1):13-20. PubMed ID: 23449774
[TBL] [Abstract][Full Text] [Related]
11. Low flow vascular malformation of the buccal mucosa treated conservatively by sclerotherapy (3% sodium tetradecyl sulfate).
Candamourty R; Venkatachalam S; Babu MR; Reddy VK
J Nat Sci Biol Med; 2012 Jul; 3(2):195-8. PubMed ID: 23225986
[TBL] [Abstract][Full Text] [Related]
12. Orbital Venolymphatic Malformation Treated With Sodium Tetradecyl Sulfate: A Case Report.
Das S; Agrawal A; Burathoki SK; Nandolia KK; Juneja A; Samanta R
Cureus; 2022 Sep; 14(9):e29173. PubMed ID: 36259024
[TBL] [Abstract][Full Text] [Related]
13. Sclerotherapy using 1% sodium tetradecyl sulfate to treat a vascular malformation: a report of two cases.
Min HG; Kim SG; Oh JS; You JS
J Korean Assoc Oral Maxillofac Surg; 2015 Dec; 41(6):322-6. PubMed ID: 26734559
[TBL] [Abstract][Full Text] [Related]
14. Intralesional bleomycin injection in management of low flow vascular malformations in children.
Mohan AT; Adams S; Adams K; Hudson DA
J Plast Surg Hand Surg; 2015 Apr; 49(2):116-20. PubMed ID: 25204206
[TBL] [Abstract][Full Text] [Related]
15. Total clinical regression of an orbital macrocystic lymphatic malformation following intralesional sodium tetradecyl sulphate injection.
Kiratli H; Tarlan B
J AAPOS; 2015 Feb; 19(1):78-80. PubMed ID: 25727595
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive management of hemangioma and vascular malformation using intralesional bleomycin injection.
Hassan Y; Osman AK; Altyeb A
Ann Plast Surg; 2013 Jan; 70(1):70-3. PubMed ID: 23249476
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous intra-operative sclerotherapy and surgical resection of cervicofacial venous malformations.
MacArthur CJ; Nesbit G
Int J Pediatr Otorhinolaryngol; 2019 Mar; 118():143-146. PubMed ID: 30634101
[TBL] [Abstract][Full Text] [Related]
18. Sclerotherapy for intramuscular vascular malformations: A single-center experience.
Scorletti F; Patel MN; Hammill AM; Ricci KW; Myer CM; Dasgupta R
J Pediatr Surg; 2018 May; 53(5):1056-1059. PubMed ID: 29519571
[TBL] [Abstract][Full Text] [Related]
19. Flow characteristics of soft-tissue vascular anomalies evaluated by direct puncture scintigraphy.
Inoue Y; Ohtake T; Wakita S; Yoshioka N; Furuya F; Nishikawa J; Sasaki Y; Harii K
Eur J Nucl Med; 1997 May; 24(5):505-10. PubMed ID: 9142730
[TBL] [Abstract][Full Text] [Related]
20. MRI-guided percutaneous sclerotherapy of venous malformations: initial clinical experience using a 3T MRI system.
O'Mara DM; Berges AJ; Fritz J; Weiss CR
Clin Imaging; 2020 Sep; 65():8-14. PubMed ID: 32353719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
